TABLE 3

Kinetic models and constants for 1NP glucuronidation by human UGT isoforms


Isoform

Empirical Modelsa, b, c

Two-Site Model
Km or S50
Vmax
nd
Ks
Vmax
αe
μM pmol/min · mg protein μM pmol/min · mg protein
1A1c 345 ± 9 260 ± 6 1.3 ± 0.1 647 ± 18 249 ± 5 0.18 ± 0.02
1A3b, f 1768 ± 524 102 ± 24 1978 ± 190 87 ± 5 0.35 ± 0.12g
1A4 N.D.
1A6c 3.1 ± 0.02 19,596 ± 74 1.3 ± 0.01 6.7 ± 0.2 19,646 ± 127 0.22 ± 0.02
1A7c 1.4 ± 0.1 74 ± 2 2.3 ± 0.3 8.0 ± 0.9 77 ± 2 0.03 ± 0.01
1A8c 87 ± 6 1011 ± 37 1.5 ± 0.1 267 ± 84 1023 ± 37 0.11 ± 0.07
1A9c 1.3 ± 0.1 35 ± 0.8 2.2 ± 0.2 10 ± 1 37 ± 1 0.02 ± 0.004
1A10a 2.0 ± 0.1 1293 ± 26
2B7c 107 ± 5 44 ± 1 2.0 ± 0.2 668 ± 57 46 ± 1 0.03 ± 0.005
2B15, 2B17
N.D.





  • N.D., not determined.

  • a Michaelis-Menten, b Substrate inhibition, c Hill equation.

  • d Hill equation coefficient.

  • e Interaction factor from two-site model. β = 2, except for UGT1A3 since Vmax is equivalent to 2Kp[E]t for autoactivation (where [E]t is the total enzyme concentration).

  • f Ksi = 938 ± 303 μM.

  • g β = 0.11 ± 0.04.